Showing results (1311-1320 of 6,130) with videos related to

Sort By:
Pageof 613
International Journal of Antimicrobial Agents|January 9, 2026
Pharmacokinetics and Pharmacodynamics of Bacteriophage Therapy: A Scoping ReviewAndrew T Nguyen, Nicita Mehta, KaiLan Mackey, et al.
International Journal of Antimicrobial Agents|January 10, 2026
Pharmacokinetics of ampicillin, sulbactam, and combined ampicillin/sulbactam in subcutis, muscle, and plasma: a microdialysis trial in healthy volunteersAnselm Jorda, Lena Pracher, Marlene Prager, et al.
International Journal of Antimicrobial Agents|December 24, 2025
Antibiotic class comparisons for the treatment of pyelonephritis and complicated urinary tract infections: a systematic review and meta-analysisDigbijay Kunwar, Itay Zahavi, Judit Olchowski, et al.
International Journal of Antimicrobial Agents|November 7, 2025
Consumption and expenditure on fidaxomicin and oral vancomycin for Clostridioides difficile infection: A 12-year longitudinal study of 43 countries and regionsYin Zhang, Xue Li, Angel Y S Wong, et al.
International Journal of Antimicrobial Agents|November 1, 2025
Evaluation of sulbactam-durlobactam disk diffusion and broth microdilution methods for Acinetobacter baumanniiXiaolan Hong, Xinying Wang, Xin Xiang, et al.
International Journal of Antimicrobial Agents|October 24, 2025
Membrane-disrupting medium-chain fatty acids reduce Staphylococcus aureus persister cell survival during antibiotic treatmentYena Seo, Minjun Kim, Dae-Youn Kim, et al.
International Journal of Antimicrobial Agents|October 30, 2025
Antibiotic-mediated prophage activation: Mechanisms, consequences, and therapeutic implicationsDamir Gavric, Petar Knezevic
International Journal of Antimicrobial Agents|November 6, 2025
Two tail protein-derived capsule depolymerases from phage vB_KpnS_GH-K1 are effective against pneumonia caused by K2 serotype Klebsiella pneumoniaeGuiyang Ge, Hongbei Ge, Jianhui Xu, et al.
International Journal of Antimicrobial Agents|October 10, 2025
Overcoming antimicrobial resistance: Phage therapy as a promising solution to combat ESKAPE pathogensRitu Raj Patel, Pandey Priya Arun, Sudhir Kumar Singh, et al.
International Journal of Antimicrobial Agents|October 10, 2025
Rapid initiation of direct-acting antivirals and hepatitis C treatment outcomes in people with HIV: A real-world integrated care modelLing-Ya Chen, Hsin-Yun Sun, Yu-Shan Huang, et al.
Pageof 613